Parametric Portfolio Associates’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$791K Buy
170,404
+88,833
+109% +$381K ﹤0.01% 2890
2021
Q4
$408K Sell
81,571
-4,247
-5% -$34K ﹤0.01% 3143
2021
Q3
$1.03M Buy
85,818
+40,115
+88% +$584K ﹤0.01% 2798
2021
Q2
$967K Sell
45,703
-11,640
-20% -$280K ﹤0.01% 2787
2021
Q1
$1.61M Buy
57,343
+14,549
+34% +$429K ﹤0.01% 2922
2020
Q4
$1.11M Sell
42,794
-848
-2% -$25.4K ﹤0.01% 2990
2020
Q3
$1.62M Sell
43,642
-14,742
-25% -$584K ﹤0.01% 2639
2020
Q2
$3M Buy
58,384
+10,271
+21% +$430K ﹤0.01% 2235
2020
Q1
$1.52M Buy
48,113
+13,291
+38% +$701K ﹤0.01% 2551
2019
Q4
$2.08M Buy
34,822
+7,336
+27% +$330K ﹤0.01% 2666
2019
Q3
$1.01M Buy
27,486
+2,847
+12% +$113K ﹤0.01% 3026
2019
Q2
$1.15M Buy
24,639
+1,903
+8% +$89.4K ﹤0.01% 2987
2019
Q1
$913K Buy
22,736
+2,316
+11% +$104K ﹤0.01% 3077
2018
Q4
$939K Buy
20,420
+279
+1% +$13.4K ﹤0.01% 3018
2018
Q3
$894K Sell
20,141
-938
-4% -$43.1K ﹤0.01% 3159
2018
Q2
$826K Sell
21,079
-24,614
-54% -$1.24M ﹤0.01% 3144
2018
Q1
$3.31M Buy
45,693
+750
+2% +$55.1K ﹤0.01% 2238
2017
Q4
$2.96M Sell
44,943
-4,392
-9% -$236K ﹤0.01% 2320
2017
Q3
$2.47M Sell
49,335
-813
-2% -$39.2K ﹤0.01% 2440
2017
Q2
$2.32M Buy
50,148
+1,386
+3% +$51K ﹤0.01% 2422
2017
Q1
$1.72M Buy
48,762
+31,544
+183% +$722K ﹤0.01% 2551
2016
Q4
$216K Sell
17,218
-3,949
-19% -$47K ﹤0.01% 3567
2016
Q3
$293K Sell
21,167
-21,736
-51% -$246K ﹤0.01% 3428
2016
Q2
$424K Buy
42,903
+32,566
+315% +$540K ﹤0.01% 3277
2016
Q1
$175K Buy
+10,337
New +$166K ﹤0.01% 3771
2015
Q3
Sell
-5,203
Closed -$425K 3286
2015
Q2
$425K Buy
5,203
+775
+18% +$75.9K ﹤0.01% 3375
2015
Q1
$410K Buy
+4,428
New +$286K ﹤0.01% 3382

Other funds holding ESPR